NCT04453735View on ClinicalTrials.gov

MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

December 18, 2020

Study Completion Date

December 18, 2020

Conditions
Statin Adverse Reaction
Interventions
DRUG

Atorvastatin mylan 40 Mg Oral Tablet

Oral tablet on regular prescription

Trial Locations (2)

3004

Vestre Viken HF, Drammen Hospital, Drammen

3103

Hospital of Vestfold, Tønsberg

All Listed Sponsors
collaborator

The Hospital of Vestfold

OTHER

collaborator

Oslo University Hospital

OTHER

lead

Vestre Viken Hospital Trust

OTHER

NCT04453735 - MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study | Biotech Hunter | Biotech Hunter